Revolution Medicines (NasdaqGS:RVMD) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Company ParticipantsRyan Asay - SVP of Corporate AffairsWei Lin - CMOAlan Sandler - Chief Development OfficerSteve Kelsey - President of Research and DevelopmentAlec Stranahan - Biotechnology Equity ResearchMark Goldsmith - Chairman and CEOJenna Li - Biotech Equity Research Senior AssociateAnthony Mancini - Chief Global Commercialization OfficerConference Call ParticipantsJoseph Catanzaro - Senior Biotech Equity Analyst ...